This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:
fact-checked
peer-reviewed publication
trusted source
proofread
Findings may help researchers develop a medication-friendly grapefruit

Grapefruit and pummelo contain compounds called furanocoumarins that may affect the blood levels of more than 100 prescription drugs, so people taking these medications are advised to remove these fruits from their diets.
Research published in New Phytologist reveals genetic information about the synthesis of furanocoumarins in different citrus plant tissues and species and provides new insights that could be used to develop grapefruit and pummelo that lack furanocoumarins.
The research indicates that the production of furanocoumarins in citrus fruit is dependent on the integrity of a single gene within a multi-gene cluster that encodes enzymes of the 2-oxoglutarate-dependent dioxygenase family.
"This research helps us to understand why fruit of certain citrus species produce furanocoumarins and demonstrates how breeders and researchers could develop furanocoumarin-free citrus varieties," said co–corresponding author Yoram Eyal, Ph.D., of the Volcani Center, in Israel.
More information: A 2OGD multi-gene cluster encompasses functional and tissue specificity that direct furanocoumarin and pyranocoumarin biosynthesis in citrus, New Phytologist (2025). DOI: 10.1111/nph.20322
Journal information: New Phytologist
Provided by Wiley